Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 8/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | BHMT | Q93088 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30983358 | 1.00 | ARG1 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL5016344 | 0.83 | BHMT (0.56) | NOS2NOS1NOS3BHMT | |
| SCHEMBL9654172 | 0.83 | BHMT (0.56) | NOS2NOS1NOS3BHMT | |
| SCHEMBL5061196 | 0.81 | NOS2 (0.49) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL5061193 | 0.81 | NOS2 (0.49) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL8194703 | 0.81 | ARG1 (0.43) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL15490645 | 0.81 | CYP1A2 (0.42) | CYP2C19CYP1A2CYP2C9HTTSMN1; SMN2 | |
| SCHEMBL3685147 | 0.80 | SLC1A1 (0.46) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL3685144 | 0.80 | SLC1A1 (0.46) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL10796639 | 0.77 | CYP1A2 (0.46) | ARG1ARG2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232416-A | Preparation of heat-insulating aerogel and application of heat-insulating aerogel in energy-saving aluminum alloy door and window | 格瑞禾正(山东)节能建材有限公司 | 2022-10-25 | — | — | CN | disclosed |
| EP-0790982-B1 | METHODS OF SYNTHESIS OF PEPTIDYL ARGININALS | CORVAS INT INC (US) | 2002-02-27 | — | — | EP | disclosed |
| EP-0765340-B1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INT INC (US) | 2000-08-30 | — | — | EP | disclosed |
| US-6025472-A | PEPTIDE ALDEHYDES WHICH ARE POTENT INHIBITORS OF FACTOR XA, USEFUL AS THERAPEUTIC AGENTS FOR DISEASE STATES IN MAMMALS CHARACTERIZED BY ABNORMAL THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| EP-0765338-B1 | ARGININE MIMIC DERIVATIVES AS ENZYME INHIBITORS | CORVAS INT INC (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5883107-A | ANTITHROMBOTIC AGENTS | CORVAS INTERNATIONAL, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| US-5776927-A | THROMBIN INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5731413-A | Method of synthesis of peptidyl aldehydes | CORVAS INTERNATIONAL, INC. (US) | 1998-03-24 | — | — | US | disclosed |
| CN-1171116-A | N-substituted glycine derivatives as factor Xa inhibitors | CORVAS INT INC (US) | 1998-01-21 | — | — | CN | disclosed |
| US-5696231-A | ANTICOAGULANTS; CARDIOVASCULAR DISORDERS | CORVAS INTERNATIONAL, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| EP-0790982-A1 | METHODS OF SYNTHESIS OF PEPTIDYL ARGININALS | CORVAS INTERNATIONAL, INC. (US) | 1997-08-27 | — | — | EP | disclosed |
| US-5658939-A | PREVENTION THROMBOSIS IN MAMMALS | CORVAS INTERNATIONAL INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5646165-A | ANTITHROMBOTIC AGENTS | CORVAS INTERNATIONAL, INC. (US) | 1997-07-08 | — | — | US | disclosed |
| EP-0765340-A1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1997-04-02 | — | — | EP | disclosed |
| EP-0765338-A1 | ARGININE MIMIC DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1997-04-02 | — | — | EP | disclosed |
| WO-1996019493-A1 | N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa | CORVAS INTERNATIONAL, INC. (US) | 1996-06-27 | — | — | WO | disclosed |
| US-5514777-A | Methods of synthesis of peptidyl argininals | CORVAS INTERNATIONAL, INC. (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1995035312-A1 | ARGININE MIMIC DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1995-12-28 | — | — | WO | disclosed |
| WO-1995035280-A1 | METHODS OF SYNTHESIS OF PEPTIDYL ARGININALS | CORVAS INTERNATIONAL, INC. (US) | 1995-12-28 | — | — | WO | disclosed |
| WO-1995028420-A1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1995-10-26 | — | — | WO | disclosed |